| Aptamer | Type | Target | Stage | References |
| SM-20 | RNA | Plasminogen activator inhibitor-1 | Pre-clinical | [109,110,111] |
| WT-15 | RNA | Plasminogen activator inhibitor-1 | Pre-clinical | [109,110,111] |
| Paionap-5 | RNA | Plasminogen activator inhibitor-1 | Pre-clinical | [112] |
| Paionap-40 | RNA | Plasminogen activator inhibitor-1 | Pre-clinical | [112] |
| R10-2 | RNA | Plasminogen activator inhibitor-1 | Pre-clinical | [113] |
| R10-4 | RNA | Plasminogen activator inhibitor-1 | Pre-clinical | [113] |
| Upanap-12 | RNA | Urokinase-type plasminogen activator | Pre-clinical | [114] |
| Upanap-12.49 | RNA | Urokinase-type plasminogen activator | Pre-clinical | [114] |
| Upanap-126 | RNA | Urokinase-type plasminogen activator | Pre-clinical | [115] |
| unnamed | RNA | Urokinase-type plasminogen activator | Pre-clinical | [116] |
| K18v2 | RNA | Tissue-type plasminogen activator | Pre-clinical | [117] |
| K32v2 | RNA | Tissue-type plasminogen activator | Pre-clinical | [117] |
| 3218 | RNA | Tissue-type plasminogen activator | Pre-clinical | [118] |